1. Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, Chaboissier MC, Poulat F, Behringer RR, Lovell-Badge R, Capel B 2006 Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4:e187
2. MacLaughlin DT, Donahoe PK 2004 Sex determination and differentiation. N Engl J Med 350:367-378
3. Hughes IA, Houk C, Ahmed SF, Lee PA 2006 Consensus statement on management of intersex disorders. Arch Dis Child 91:554-563
4. Lee, PA 2006 Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 118 e488-500
5. Mendonca BB, Domenice S, Arnhold IJ, Costa EM 2008 46,XY disorders of sex development. Clin Endocrinol (Oxf)
6. Griffin J, McPhaul M, Russell D, Wilson J 1995 The androgen resistance syndrome: Steroid 5a-reductase 2 deficiency, testicular feminization, and related disordes. In: Scriver CR BA, Sly WS, Vale D ed. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill; 2967-
7. Lee MM, Misra M, Donahoe PK, MacLaughlin DT 2003 MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 211:91-98
8. Lahlou N, Roger M 2004 Inhibin B in pubertal development and pubertal disorders. Semin Reprod Med 22:165-175
9. Arnhold IJ, Mendonca BB, Diaz JA, Nogueira C, Batista MC, Madureira G, Oliveira D, Nicolau W, Bloise W 1988 Prepubertal male pseudohermaphroditism due to 17-ketosteroid reductase deficiency: diagnostic value of a hCG test and lack of HLA association. J Endocrinol Invest 11:319-322
10. Garel L 2008 Abnormal sex differentiation: who, how and when to image. Pediatr Radiol 38 Suppl 3:S508-511
11. Parker KL 1998 The roles of steroidogenic factor 1 in endocrine development and function. Mol Cell Endocrinol 140:59-63.
12. Parker KL, Schedl A, Schimmer BP 1999 Gene interactions in gonadal development. Annu Rev Physiol 61:417-433
13. Wilhelm D, Englert C 2002 The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev 16:1839-1851
14. De Santa Barbara P, Bonneaud N, Boizet B, Desclozeaux M, Moniot B, Sudbeck P, Scherer G, Poulat F, Berta P 1998 Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 18:6653-6665
15. Giuili G, Shen WH, Ingraham HA 1997 The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo. Development 124:1799-1807.
16. Berta P, Hawkins JR, Sinclair AH, Taylor A, Griffiths BL, Goodfellow PN, Fellous M 1990 Genetic evidence equating SRY and the testis-determining factor. Nature 348:448-450.
17. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN 1990 A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240-244.
18. Giese K, Pagel J, Grosschedl R 1994 Distinct DNA-binding properties of the high mobility group domain of murine and human SRY sex-determining factors. Proc Natl Acad Sci U S A 91:3368-3372.
19. Cory AT, Boyer A, Pilon N, Lussier JG, Silversides DW 2007 Presumptive pre-Sertoli cells express genes involved in cell proliferation and cell signalling during a critical window in early testis differentiation. Mol Reprod Dev 74:1491-1504
20. Bernard P, Sim H, Knower K, Vilain E, Harley V 2008 Human SRY inhibits beta-catenin-mediated transcription. Int J Biochem Cell Biol 40:2889-2900
21. Maatouk DM, DiNapoli L, Alvers A, Parker KL, Taketo MM, Capel B 2008 Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. Hum Mol Genet 17:2949-2955
22. De Marchi M, Campagnoli C, Ghiringhello B, Ponzio G, Carbonara A 1981 Gonadal agenesis in a phenotypically normal female with positive H-Y antigen. Hum Genet 56:417-419
23. Mendonca BB, Barbosa AS, Arnhold IJ, McElreavey K, Fellous M, Moreira-Filho CA 1994 Gonadal agenesis in XX and XY sisters: evidence for the involvement of an autosomal gene. Am J Med Genet 52:39-43
24. Ottolenghi C, Moreira-Filho C, Mendonca BB, Barbieri M, Fellous M, Berkovitz GD, McElreavey K 2001 Absence of mutations involving the LIM homeobox domain gene LHX9 in 46,XY gonadal agenesis and dysgenesis. J Clin Endocrinol Metab 86:2465-2469.
25. Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CH 2004 Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363:2128-2135
26. Swyer GI 1955 Male pseudohermaphroditism: a hitherto undescribed form. Br Med J:709-712
27. Vilain E, Elreavey KM, Richaud F, Fellous M 1992 [Sex genetics]. Presse Med 21:852-856.
28. Hawkins JR 1993 Mutational analysis of SRY in XY females. Hum Mutat 2:347-350
29. McElreavey K, Vilain E, Barbaux S, Fuqua JS, Fechner PY, Souleyreau N, Doco-Fenzy M, Gabriel R, Quereux C, Fellous M, Berkovitz GD 1996 Loss of sequences 3' to the testis-determining gene, SRY, including the Y pseudoautosomal boundary associated with partial testicular determination. Proc Natl Acad Sci U S A 93:8590-8594
30. Vilain E, McElreavey K, Jaubert F, Raymond JP, Richaud F, Fellous M 1992 Familial case with sequence variant in the testis-determining region associated with two sex phenotypes. Am J Hum Genet 50:1008-1011
31. Harley VR, Jackson DI, Hextall PJ, Hawkins JR, Berkovitz GD, Sockanathan S, Lovell-Badge R, Goodfellow PN 1992 DNA binding activity of recombinant SRY from normal males and XY females. Science 255:453-456.
32. Schmitt-Ney M, Thiele H, Kaltwasser P, Bardoni B, Cisternino M, Scherer G 1995 Two novel SRY missense mutations reducing DNA binding identified in XY females and their mosaic fathers. Am J Hum Genet 56:862-869.
33. Assumpcao JG, Benedetti CE, Maciel-Guerra AT, Guerra G, Jr., Baptista MT, Scolfaro MR, de Mello MP 2002 Novel mutations affecting SRY DNA-binding activity: the HMG box N65H associated with 46,XY pure gonadal dysgenesis and the familial non-HMG box R30I associated with variable phenotypes. J Mol Med 80:782-790
34. Dumic M, Lin-Su K, Leibel NI, Ciglar S, Vinci G, Lasan R, Nimkarn S, Wilson JD, McElreavey K, New MI 2008 Report of fertility in a woman with a predominantly 46,XY karyotype in a family with multiple disorders of sexual development. J Clin Endocrinol Metab 93:182-189
35. Josso N, Briard ML 1980 Embryonic testicular regression syndrome: variable phenotypic expression in siblings. J Pediatr 97:200-204.
36. Berkovitz GD, Fechner PY, Zacur HW, Rock JA, Snyder HM, 3rd, Migeon CJ, Perlman EJ 1991 Clinical and pathologic spectrum of 46,XY gonadal dysgenesis: its relevance to the understanding of sex differentiation. Medicine (Baltimore) 70:375-383
37. Riccardi VM, Sujansky E, Smith AC, Francke U 1978 Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 61:604-610
38. van Heyningen V, Bickmore WA, Seawright A, Fletcher JM, Maule J, Fekete G, Gessler M, Bruns GA, Huerre-Jeanpierre C, Junien C, et al. 1990 Role for the Wilms tumor gene in genital development? Proc Natl Acad Sci U S A 87:5383-5386
39. Tiberio G, Digilio MC, Giannotti A 2000 Obesity and WAGR syndrome. Clin Dysmorphol 9:63-64
40. Le Caignec C, Delnatte C, Vermeesch JR, Boceno M, Joubert M, Lavenant F, David A, Rival JM 2007 Complete sex reversal in a WAGR syndrome patient. Am J Med Genet A 143A:2692-2695
41. Mueller RF 1994 The Denys-Drash syndrome. J Med Genet 31:471-477
42. Baird PN, Santos A, Groves N, Jadresic L, Cowell JK 1992 Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1:301-305
43. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, et al. 1991 Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447.
44. Gwin K, Cajaiba MM, Caminoa-Lizarralde A, Picazo ML, Nistal M, Reyes-Mugica M 2008 Expanding the clinical spectrum of Frasier syndrome. Pediatr Dev Pathol 11:122-127
45. Reddy JC 1996 The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochim Biophys Acta 1287:1-28
46. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE 1991 Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci U S A 88:9618-9622
47. Melo KF, Martin RM, Costa EM, Carvalho FM, Jorge AA, Arnhold IJ, Mendonca BB 2002 An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J Clin Endocrinol Metab 87:2500-2505
48. Drash A, Sherman F, Hartmann WH, Blizzard RM 1970 A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76:585-593.
49. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K 1997 Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17:467-470.
50. Kohsaka T, Tagawa M, Takekoshi Y, Yanagisawa H, Tadokoro K, Yamada M 1999 Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome. Hum Mutat 14:466-470
51. Barbosa AS, Hadjiathanasiou CG, Theodoridis C, Papathanasiou A, Tar A, Merksz M, Gyorvari B, Sultan C, Dumas R, Jaubert F, Niaudet P, Moreira-Filho CA, Cotinot C, Fellous M 1999 The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum Mutat 13:146-153
52. Lala DS, Rice DA, Parker KL 1992 Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 6:1249-1258.
53. Luo X, Ikeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490.
54. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW, Abbud R, Nilson JH, Parker KL 1994 The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 8:2302-2312
55. Achermann JC, Ito M, Hindmarsh PC, Jameson JL 1999 A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125-126.
56. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, Gurakan B, Jameson JL 2002 Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 87:1829-1833.
57. Correa RV DS, Bingham NC, Billerbeck AE, Rainey WE, Parker KL, Mendonca BB. 2004 A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab 89(4):1767-72
58. Kohler B, Lin L, Ferraz-de-Souza B, Wieacker P, Heidemann P, Schroder V, Biebermann H, Schnabel D, Gruters A, Achermann JC 2008 Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency. Hum Mutat 29:59-64
59. Lin L, Philibert P, Ferraz-de-Souza B, Kelberman D, Homfray T, Albanese A, Molini V, Sebire NJ, Einaudi S, Conway GS, Hughes IA, Jameson JL, Sultan C, Dattani MT, Achermann JC 2007 Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab 92:991-999
60. Jeyasuria P, Ikeda Y, Jamin SP, Zhao L, De Rooij DG, Themmen AP, Behringer RR, Parker KL 2004 Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol 18:1610-1619
61. Urs AN, Dammer E, Kelly S, Wang E, Merrill AH, Jr., Sewer MB 2007 Steroidogenic factor-1 is a sphingolipid binding protein. Mol Cell Endocrinol 265-266:174-178
62. Philibert P, Zenaty D, Lin L, Soskin S, Audran F, Leger J, Achermann JC, Sultan C 2007 Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod 22:3255-3261
63. Coutant R, Mallet D, Lahlou N, Bouhours-Nouet N, Guichet A, Coupris L, Croue A, Morel Y 2007 Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome. J Clin Endocrinol Metab 92:2868-2873
64. Raymond CS, Murphy MW, O'Sullivan MG, Bardwell VJ, Zarkower D 2000 Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes Dev 14:2587-2595
65. Raymond CS, Parker ED, Kettlewell JR, Brown LG, Page DC, Kusz K, Jaruzelska J, Reinberg Y, Flejter WL, Bardwell VJ, Hirsch B, Zarkower D 1999 A region of human chromosome 9p required for testis development contains two genes related to known sexual regulators. Hum Mol Genet 8:989-996
66. Raymond CS, Shamu CE, Shen MM, Seifert KJ, Hirsch B, Hodgkin J, Zarkower D 1998 Evidence for evolutionary conservation of sex-determining genes. Nature 391:691-695
67. Muroya K, Okuyama T, Goishi K, Ogiso Y, Fukuda S, Kameyama J, Sato H, Suzuki Y, Terasaki H, Gomyo H, Wakui K, Fukushima Y, Ogata T 2000 Sex-determining gene(s) on distal 9p: clinical and molecular studies in six cases. J Clin Endocrinol Metab 85:3094-3100
68. Gibbons RJ, Higgs DR 2000 Molecular-clinical spectrum of the ATR-X syndrome. Am J Med Genet 97:204-212.
69. Wilkie AO, Gibbons RJ, Higgs DR, Pembrey ME 1991 X linked alpha thalassaemia/mental retardation: spectrum of clinical features in three related males. J Med Genet 28:738-741.
70. Gibbons RJ, Picketts DJ, Villard L, Higgs DR 1995 Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell 80:837-845
71. Thienpont B, Breckpot J, Vermeesch JR, Gewillig M, Devriendt K 2008 A complex submicroscopic chromosomal imbalance in 19p13.11 with one microduplication and two microtriplications. Eur J Med Genet 51:219-225
72. Tang P, Park DJ, Marshall Graves JA, Harley VR 2004 ATRX and sex differentiation. Trends Endocrinol Metab 15:339-344
73. Badens C, Lacoste C, Philip N, Martini N, Courrier S, Giuliano F, Verloes A, Munnich A, Leheup B, Burglen L, Odent S, Van Esch H, Levy N 2006 Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. Clin Genet 70:57-62
74. Gibbons RJ, Wada T, Fisher CA, Malik N, Mitson MJ, Steensma DP, Fryer A, Goudie DR, Krantz ID, Traeger-Synodinos J 2008 Mutations in the chromatin-associated protein ATRX. Hum Mutat 29:796-802
75. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley KC, Tonini G, Ferrante E, Chiumello G, McCabe ER, Fraccaro M, et al. 1994 A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 7:497-501.
76. Barbaro M, Oscarson M, Schoumans J, Staaf J, Ivarsson SA, Wedell A 2007 Isolated 46,XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab 92:3305-3313
77. Barbaro M, Cicognani A, Balsamo A, Lofgren A, Baldazzi L, Wedell A, Oscarson M 2008 Gene dosage imbalances in patients with 46,XY gonadal DSD detected by an in-house-designed synthetic probe set for multiplex ligation-dependent probe amplification analysis. Clin Genet 73:453-464
78. Smyk M, Berg JS, Pursley A, Curtis FK, Fernandez BA, Bien-Willner GA, Lupski JR, Cheung SW, Stankiewicz P 2007 Male-to-female sex reversal associated with an approximately 250 kb deletion upstream of NR0B1 (DAX1). Hum Genet 122:63-70
79. Stark K, Vainio S, Vassileva G, McMahon AP 1994 Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372:679-683.
80. Elejalde BR, Opitz JM, de Elejalde MM, Gilbert EF, Abellera M, Meisner L, Lebel RR, Hartigan JM 1984 Tandem dup (1p) within the short arm of chromosome 1 in a child with ambiguous genitalia and multiple congenital anomalies. Am J Med Genet 17:723-730
81. Jordan BK, Mohammed M, Ching ST, Delot E, Chen XN, Dewing P, Swain A, Rao PN, Elejalde BR, Vilain E 2001 Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet 68:1102-1109
82. Foster JW, Dominguez-Steglich MA, Guioli S, Kowk G, Weller PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN, et al. 1994 Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530.
83. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, et al. 1994 Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120.
84. Kwok C, Weller PA, Guioli S, Foster JW, Mansour S, Zuffardi O, Punnett HH, Dominguez-Steglich MA, Brook JD, Young ID, et al. 1995 Mutations in SOX9, the gene responsible for Campomelic dysplasia and autosomal sex reversal. Am J Hum Genet 57:1028-1036
85. Pop R, Conz C, Lindenberg KS, Blesson S, Schmalenberger B, Briault S, Pfeifer D, Scherer G 2004 Screening of the 1 Mb SOX9 5' control region by array CGH identifies a large deletion in a case of campomelic dysplasia with XY sex reversal. J Med Genet 41:e47
86. Velagaleti GV, Bien-Willner GA, Northup JK, Lockhart LH, Hawkins JC, Jalal SM, Withers M, Lupski JR, Stankiewicz P 2005 Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia. Am J Hum Genet 76:652-662
87. Tate G SH, Endo Y, Mitsuya T. 2000 Assignment of desert hedgehog (DHH) to human chromosome bands 12q12-->q13.1 by in situ hybridization. . Cytogenet Cell Genet ;88(1-2):93-4)
88. Umehara F, Tate G, Itoh K, Yamaguchi N, Douchi T, Mitsuya T, Osame M 2000 A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 67:1302-1305
89. Canto P SD, Reyes E, Mendez JP. 2004 Mutations in the desert hedgehog (DHH) gene in patients with 46,XY complete pure gonadal dysgenesis. J Clin Endocrinol Metab; 89(9):4480-3),
90. Canto P, Vilchis F, Soderlund D, Reyes E, Mendez JP 2005 A heterozygous mutation in the desert hedgehog gene in patients with mixed gonadal dysgenesis. Mol Hum Reprod 11:833-836
91. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G 1994 Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330:107-113
92. Opitz JM 1994 RSH/SLO ("Smith-Lemli-Opitz") syndrome: historical, genetic, and developmental considerations. Am J Med Genet 50:344-346
93. Fukazawa R, Nakahori Y, Kogo T, Kawakami T, Akamatsu H, Tanae A, Hibi I, Nagafuchi S, Nakagome Y, Hirayama T 1992 Normal Y sequences in Smith-Lemli-Opitz syndrome with total failure of masculinization. Acta Paediatr 81:570-572
94. Joseph DB, Uehling DT, Gilbert E, Laxova R 1987 Genitourinary abnormalities associated with the Smith-Lemli-Opitz syndrome. J Urol 137:719-721
95. Andersson, C H 1999 Adrenal insufficiency in Smith-Lemli-Opitz syndrome. Am J Med Genet 82:382-384
96. Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise W, Castro M, Tsigos C, Chrousos GP 1996 Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 334:507-512.
97. Laue LL, Wu SM, Kudo M, Bourdony CJ, Cutler GB, Jr., Hsueh AJ, Chan WY 1996 Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 10:987-997.
98. Berthezene F, Forest MG, Grimaud JA, Claustrat B, Mornex R 1976 Leydig-cell agenesis: a cause of male pseudohermaphroditism. N Engl J Med 295:969-972.
99. Brown DM, Markland C, Dehner LP 1978 Leydig cell hypoplasia: a cause of male pseudohermaphroditism. J Clin Endocrinol Metab 46:1-7.
100. Eil C, Austin RM, Sesterhenn I, Dunn JF, Cutler GB, Jr., Johnsonbaugh RE 1984 Leydig cell hypoplasia causing male pseudohermaphroditism: diagnosis 13 years after prepubertal castration. J Clin Endocrinol Metab 58:441-448.
101. Schwartz M, Imperato-McGinley J, Peterson RE, Cooper G, Morris PL, MacGillivray M, Hensle T 1981 Male pseudohermaphroditism secondary to an abnormality in Leydig cell differentiation. J Clin Endocrinol Metab 53:123-127.
102. Lee PA, Rock JA, Brown TR, Fichman KM, Migeon CJ, Jones HW, Jr. 1982 Leydig cell hypofunction resulting in male pseudohermaphroditism. Fertil Steril 37:675-679.
103. Arnhold IJ, Mendonca BB, Bloise W, Toledo SP 1985 Male pseudohermaphroditism resulting from Leydig cell hypoplasia. J Pediatr 106:1057
104. Arnhold IJ, de Mendonca BB, Toledo SP, Madureira G, Nicolau W, Bisi H, Bloise W 1987 Leydig cell hypoplasia causing male pseudohermaphroditism: case report and review of the literature. Rev Hosp Clin Fac Med Sao Paulo 42:227-232
105. Arnhold IJ, Mendonca BB, Bisi H, Russo FO, Nicolau W, Bloise W, Moreira-Filho CA 1988 Normal expression of the serologically defined H-Y antigen in Leydig cell hypoplasia. J Urol 140:1549-1552
106. Saldanha PH, Arnhold IJ, Mendonca BB, Bloise W, Toledo SP 1987 A clinico-genetic investigation of Leydig cell hypoplasia. Am J Med Genet 26:337-344.
107. Latronico AC 2000 Naturally occurring mutations of the luteinizing hormone receptor gene affecting reproduction. Semin Reprod Med 18:17-20
108. Latronico AC, Arnhold IJ 2006 Inactivating mutations of LH and FSH receptors--from genotype to phenotype. Pediatr Endocrinol Rev 4:28-31
109. Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB, Segaloff DL 1998 A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 12:442-450.
110. Laue L, Wu SM, Kudo M, Hsueh AJ, Cutler GB, Jr., Griffin JE, Wilson JD, Brain C, Berry AC, Grant DB, et al. 1995 A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 4:1429-1433
111. Martens J, Lumbroso S, Verhoef-Post M, Georget V, Richter-Unruh A, Szarras-Czapnik M, Romer T, Brunner H, Themmen A, Sultan C 2002 Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency J Clin Endocrinol Metab 87: 2506-2513.).
112. Martens JW, Verhoef-Post M, Abelin N, Ezabella M, Toledo SP, Brunner HG, Themmen AP 1998 A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 12:775-784.
113. Misrahi M, Meduri G, Pissard S, Bouvattier C, Beau I, Loosfelt H, Jolivet A, Rappaport R, Milgrom E, Bougneres P 1997 Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 82:2159-2165
114. Toledo SP, Arnhold IJ, Luthold W, Russo EM, Saldanha PH 1985 Leydig cell hypoplasia determining familial hypergonadotropic hypogonadism. Prog Clin Biol Res 200:311-314
115. Stavrou SS, Zhu YS, Cai LQ, Katz MD, Herrera C, Defillo-Ricart M, Imperato-McGinley J 1998 A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 83:2091-2098.
116. Zenteno JC CP, Kofman-Alfaro S, Mendez JP 1999 Evidence for genetic heterogeneity in male pseudohermaphroditism due to Leydig cell hypoplasia. J Clin Endocrinol Metab 84:3803-6
117. Kossack N, Simoni M, Richter-Unruh A, Themmen AP, Gromoll J 2008 Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med 5:e88
118. Arnhold IJ, Latronico AC, Batista MC, Izzo CR, Mendonca BB 1999 Clinical features of women with resistance to luteinizing hormone. Clin Endocrinol (Oxf) 51:701-707
119. Arnhold IJ, Latronico AC, Batista MC, Carvalho FM, Chrousos GP, Mendonca BB 1997 Ovarian resistance to luteinizing hormone: a novel cause of amenorrhea and infertility. Fertil Steril 67:394-397
120. Abdulhadi-Atwan M, Jean A, Chung WK, Meir K, Ben Neriah Z, Stratigopoulos G, Oberfield SE, Fennoy I, Hirsch HJ, Bhangoo A, Ten S, Lerer I, Zangen DH 2007 Role of a founder c.201_202delCT mutation and new phenotypic features of congenital lipoid adrenal hyperplasia in Palestinians. J Clin Endocrinol Metab 92:4000-4008
121. Prader A, Gurtner HP 1955 [The syndrome of male pseudohermaphrodism in congenital adrenocortical hyperplasia without overproduction of androgens (adrenal male pseudohermaphrodism).]. Helv Paediatr Acta 10:397-412
122. Miller WL 1988 Molecular biology of steroid hormone synthesis. Endocr Rev 9:295-318
123. Hauffa BP, Miller WL, Grumbach MM, Conte FA, Kaplan SL 1985 Congenital adrenal hyperplasia due to deficient cholesterol side-chain cleavage activity (20, 22-desmolase) in a patient treated for 18 years. Clin Endocrinol (Oxf) 23:481-493
124. Baker BY, Lin L, Kim CJ, Raza J, Smith CP, Miller WL, Achermann JC 2006 Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J Clin Endocrinol Metab 91:4781-4785
125. Lin D, Gitelman SE, Saenger P, Miller WL 1991 Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. J Clin Invest 88:1955-1962.
126. Bose HS, Sugawara T, Strauss JF, 3rd, Miller WL 1996 The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 335:1870-1878
127. Abdulhadi-Atwan, M 2007 Role of a Founder c.201_202delCT Mutation and New Phenotypic Features of Congenital Lipoid Adrenal Hyperplasia in Palestinians. JCEM 92:4000-4008
128. Tajima T, Fujieda K, Kouda N, Nakae J, Miller WL 2001 Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86:3820-3825.
129. Kim CJ, Lin L, Huang N, Quigley CA, Avruskin TW, Achermann JC, Miller WL 2008 Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, p450scc. J Clin Endocrinol Metab 93:696-702
130. Bongiovanni AM 1962 The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase. J Clin Invest 41:2086-2092
131. Mason JI, Ushijima K, Doody KM, Nagai K, Naville D, Head JR, Milewich L, Rainey WE, Ralph MM 1993 Regulation of expression of the 3 beta-hydroxysteroid dehydrogenases of human placenta and fetal adrenal. J Steroid Biochem Mol Biol 47:151-159.
132. Rheaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI, Labrie F 1992 Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nat Genet 1:239-245
133. Mendonca BB, Bloise W, Arnhold IJ, Batista MC, Toledo SP, Drummond MC, Nicolau W, Mattar E 1987 Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty. J Steroid Biochem 28:669-675.
134. Moisan AM, Ricketts ML, Tardy V, Desrochers M, Mebarki F, Chaussain JL, Cabrol S, Raux-Demay MC, Forest MG, Sippell WG, Peter M, Morel Y, Simard J 1999 New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J Clin Endocrinol Metab 84:4410-4425
135. Simard J, Rheaume E, Mebarki F, Sanchez R, New MI, Morel Y, Labrie F 1995 Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. J Steroid Biochem Mol Biol 53:127-138.
136. Sutcliffe RG, Russell AJ, Edwards CR, Wallace AM 1996 Human 3 beta-hydroxysteroid dehydrogenase: genes and phenotypes. J Mol Endocrinol 17:1-5
137. Russell AJ, Wallace AM, Forest MG, Donaldson MD, Edwards CR, Sutcliffe RG 1994 Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. J Mol Endocrinol 12:225-237.
138. Mendonca BB, Russell AJ, Vasconcelos-Leite M, Arnhold IJ, Bloise W, Wajchenberg BL, Nicolau W, Sutcliffe RG, Wallace AM 1994 Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. J Mol Endocrinol 12:119-122.
139. Biglieri EG, Herron MA, Brust N 1966 17-hydroxylation deficiency in man. J Clin Invest 45:1946-1954
140. New MI 1970 Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. J Clin Invest 49:1930-1941.
141. Yanase T, Simpson ER, Waterman MR 1991 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12:91-108
142. Auchus RJ 2001 The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 30:101-119, vii
143. Zachmann M 1992 Recent aspects of steroid biosynthesis in male sex differentiation. Clinical studies. Horm Res 38:211-216
144. Martin RM, Lin CJ, Costa EM, de Oliveira ML, Carrilho A, Villar H, Longui CA, Mendonca BB 2003 P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 88:5739-5746
145. Matteson KJ, Picado-Leonard J, Chung BC, Mohandas TK, Miller WL 1986 Assignment of the gene for adrenal P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase) to human chromosome 10. J Clin Endocrinol Metab 63:789-791
146. Rosa S 2007 P450c17 deficiency: clinical and molecular characterization of six patients. J Clin Endocrinol Metab 92:1000-1007
147. Zachmann M, Vollmin JA, Hamilton W, Prader A 1972 Steroid 17,20-desmolase deficiency: a new cause of male pseudohermaphroditism. Clin Endocrinol (Oxf) 1:369-385.
148. Geller DH, Auchus RJ, Miller WL 1999 P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Mol Endocrinol 13:167-175.
149. Saez JM, De Peretti E, Morera AM, David M, Bertrand J 1971 Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo. J Clin Endocrinol Metab 32:604-610.
150. Boehmer AL, Brinkmann AO, Sandkuijl LA, Halley DJ, Niermeijer MF, Andersson S, de Jong FH, Kayserili H, de Vroede MA, Otten BJ, Rouwe CW, Mendonca BB, Rodrigues C, Bode HH, de Ruiter PE, Delemarre-van de Waal HA, Drop SL 1999 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 84:4713-4721.
151. Andersson S, Moghrabi N 1997 Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 62:143-147.
152. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, New MI, Schwarz HP, Blethen SL, Mendonca BB, Bloise W, Witchel SF, Cutler GB, Jr., Griffin JE, Wilson JD, Russel DW 1996 Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 81:130-136
153. Lee YS, Kirk JM, Stanhope RG, Johnston DI, Harland S, Auchus RJ, Andersson S, Hughes IA 2007 Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxf) 67:20-28
154. Mendonca BB, Inacio M, Arnhold IJ, Costa EM, Bloise W, Martin RM, Denes FT, Silva FA, Andersson S, Lindqvist A, Wilson JD 2000 Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 79:299-309.
155. Bertelloni S, Maggio MC, Federico G, Baroncelli G, Hiort O 2006 17beta-hydroxysteroid dehydrogenase-3 deficiency: a rare endocrine cause of male-to-female sex reversal. Gynecol Endocrinol 22:488-494
156. Rosler A, Silverstein S, Abeliovich D 1996 A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 81:1827-1831.
157. Wilson JD 2001 Androgens, androgen receptors, and male gender role behavior. Horm Behav 40:358-366.
158. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E 1979 Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency. N Engl J Med 300:1233-1237.
159. Imperato-McGinley J, Peterson RE, Stoller R, Goodwin WE 1979 Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J Clin Endocrinol Metab 49:391-395
160. Rosler A, Kohn G 1983 Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role. J Steroid Biochem 19:663-674.
161. Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C 1985 Male pseudohermaphroditism due to multiple defects in steroid- biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 313:1182-1191.
162. Shephard EA, Phillips IR, Santisteban I, West LF, Palmer CN, Ashworth A, Povey S 1989 Isolation of a human cytochrome P-450 reductase cDNA clone and localization of the corresponding gene to chromosome 7q11.2. Ann Hum Genet 53 ( Pt 4):291-301
163. Shackleton C, Marcos J, Arlt W, Hauffa BP 2004 Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. Am J Med Genet A 129:105-112
164. Hassell S, Butler MG 1994 Antley-Bixler syndrome: report of a patient and review of literature. Clin Genet 46:372-376
165. Reardon W, Smith A, Honour JW, Hindmarsh P, Das D, Rumsby G, Nelson I, Malcolm S, Ades L, Sillence D, Kumar D, DeLozier-Blanchet C, McKee S, Kelly T, McKeehan WL, Baraitser M, Winter RM 2000 Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J Med Genet 37:26-32
166. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, Vliet GV, Sack J, Fluck CE, Miller WL 2005 Diversity and function of mutations in p450 oxidoreductase in patients with antley-bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76:729-749
167. Hegesh E, Hegesh J, Kaftory A 1986 Congenital methemoglobinemia with a deficiency of cytochrome b5. N Engl J Med 314:757-761
168. Giordano SJ, Kaftory A, Steggles AW 1994 A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism. Hum Genet 93:568-570
169. Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD 1974 Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 291:944-949.
170. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE 1974 Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186:1213-1215.
171. Russell DW, Wilson JD 1994 Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem 63:25-61
172. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW 1993 Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 92:903-910.
173. Wigley WC, Prihoda JS, Mowszowicz I, Mendonca BB, New MI, Wilson JD, Russell DW 1994 Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme. Biochemistry 33:1265-1270.
174. Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW 1992 Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 90:799-809.
175. Andersson S, Berman DM, Jenkins EP, Russell DW 1991 Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354:159-161.
176. Mendonca BB, Inacio M, Costa EM, Arnhold IJ, Silva FA, Nicolau W, Bloise W, Russel DW, Wilson JD 1996 Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 75:64-76.
177. Imperato-McGinley J 1997 5 alpha-reductase-2 deficiency. Curr Ther Endocrinol Metab 6:384-387
178. Mendonca BB 2003 Male pseudohermaphroditism due to 5 alpha reductase 2 deficiency: outcome of a Brazilian cohort. Endocrinologist 13:201-204
179. Imperato-McGinley J, Peterson RE, Gautier T, Arthur A, Shackleton C 1985 Decreased urinary C19 and C21 steroid 5 alpha-metabolites in parents of male pseudohermaphrodites with 5 alpha-reductase deficiency: detection of carriers. J Clin Endocrinol Metab 60:553-558.
180. Wilson JD, Griffin JE, Russell DW 1993 Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 14:577-593.
181. Imperato-McGinley J, Miller M, Wilson JD, Peterson RE, Shackleton C, Gajdusek DC 1991 A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf) 34:293-298.
182. Chavez B, Valdez E, Vilchis F 2000 Uniparental disomy in steroid 5alpha-reductase 2 deficiency. J Clin Endocrinol Metab 85:3147-3150.
183. Quigley CA DBA, Marschke KB, el-Awady MK, Wilson EM, French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321
184. Brown TR, Lubahn DB, Wilson EM, Joseph DR, French FS, Migeon CJ 1988 Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci U S A 85:8151-8155.
185. Damiani D 2003 Re "Persistence of Mullerian remnants in complete androgen insensitivity syndrome". J Pediatr Endocrinol Metab 16:799
186. Melo KF, Mendonca BB, Billerbeck AE, Costa EM, Inacio M, Silva FA, Leal AM, Latronico AC, Arnhold IJ 2003 Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J Clin Endocrinol Metab 88:3241-3250
187. McPhaul 1999 Molecular defects of the androgen receptor. J Steroid Biochem Mol Biol 69:315-22
188. Kohler B, Lumbroso S, Leger J, Audran F, Grau ES, Kurtz F, Pinto G, Salerno M, Semitcheva T, Czernichow P, Sultan C 2005 Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J Clin Endocrinol Metab 90:106-111
189. Holterhus PM, Werner R, Hoppe U, Bassler J, Korsch E, Ranke MB, Dorr HG, Hiort O 2005 Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations. J Mol Med 83:1005-1013
190. Adachi M TR, Tomura A, Imasaki K, Kato S, Goto K, Yanase T, Ikuyama S, Nawata H . 2000 Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med 343:856-62)
191. Cox MB, Riggs DL, Hessling M, Schumacher F, Buchner J, Smith DF 2007 FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity. Mol Endocrinol 21:2956-2967
192. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF 2005 Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol 19:1654-1666
193. Wisniewski AB, Migeon CJ, Meyer-Bahlburg HF, Gearhart JP, Berkovitz GD, Brown TR, Money J 2000 Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J Clin Endocrinol Metab 85:2664-2669.
194. Danilovic DL, Correa PH, Costa EM, Melo KF, Mendonca BB, Arnhold IJ 2007 Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. Osteoporos Int 18:369-374
195. Rodien P, Mebarki F, Mowszowicz I, Chaussain JL, Young J, Morel Y, Schaison G 1996 Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 81:2994-2998
196. Boehmer AL, Brinkmann AO, Nijman RM, Verleun-Mooijman MC, de Ruiter P, Niermeijer MF, Drop SL 2001 Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability. J Clin Endocrinol Metab 86:1240-1246
197. Migeon CJ, Wisniewski AB, Gearhart JP, Meyer-Bahlburg HF, Rock JA, Brown TR, Casella SJ, Maret A, Ngai KM, Money J, Berkovitz GD 2002 Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome. Pediatrics 110:e31
198. Josso N, di Clemente N, Gouedard L 2001 Anti-Mullerian hormone and its receptors. Mol Cell Endocrinol 179:25-32.
199. Josso N 1995 Paediatric applications of anti-mullerian hormone research. 1992 Andrea Prader Lecture. Horm Res 43:243-248
200. Cohen-Haguenauer O, Picard JY, Mattei MG, Serero S, Nguyen VC, de Tand MF, Guerrier D, Hors-Cayla MC, Josso N, Frezal J 1987 Mapping of the gene for anti-mullerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 44:2-6
201. Josso N, di Clemente N 1999 TGF-beta Family Members and Gonadal Development. Trends Endocrinol Metab 10:216-222.
202. Guerrier D, Tran D, Vanderwinden JM, Hideux S, Van Outryve L, Legeai L, Bouchard M, Van Vliet G, De Laet MH, Picard JY, et al. 1989 The persistent Mullerian duct syndrome: a molecular approach. J Clin Endocrinol Metab 68:46-52.
203. Imbeaud S, Faure E, Lamarre I, Mattei MG, di Clemente N, Tizard R, Carre-Eusebe D, Belville C, Tragethon L, Tonkin C, et al. 1995 Insensitivity to anti-mullerian hormone due to a mutation in the human anti-mullerian hormone receptor. Nat Genet 11:382-388.
204. Imbeaud S, Carre-Eusebe D, Rey R, Belville C, Josso N, Picard JY 1994 Molecular genetics of the persistent mullerian duct syndrome: a study of 19 families. Hum Mol Genet 3:125-131.
205. Josso N, Picard JY, Rey R, di Clemente N 2006 Testicular anti-Mullerian hormone: history, genetics, regulation and clinical applications. Pediatr Endocrinol Rev 3:347-358
206. Loeff DS, Imbeaud S, Reyes HM, Meller JL, Rosenthal IM 1994 Surgical and genetic aspects of persistent mullerian duct syndrome. J Pediatr Surg 29:61-65.
207. Aarskog D 1979 Maternal progestins as a possible cause of hypospadias. N Engl J Med 300:75-78
208. Driscoll SG, Taylor SH 1980 Effects of prenatal maternal estrogen on the male urogenital system. Obstet Gynecol 56:537-542
209. Watanabe M 2007 Haplotype analysis of the estrogen receptor 1 gene in male genital and reproductive abnormalities. Hum Reprod 22 1279-1284
210. Vilela ML, Willingham E, Buckley J, Liu BC, Agras K, Shiroyanagi Y, Baskin LS 2007 Endocrine disruptors and hypospadias: role of genistein and the fungicide vinclozolin. Urology 70:618-621
211. Fredell L, Lichtenstein P, Pedersen NL, Svensson J, Nordenskjold A 1998 Hypospadias is related to birth weight in discordant monozygotic twins. J Urol 160:2197-2199
212. Francois I, van Helvoirt M, de Zegher F 1999 Male pseudohermaphroditism related to complications at conception, in early pregnancy or in prenatal growth. Horm Res 51:91-95
213. Mendonca BB, Billerbeck AE, de Zegher F 2001 Nongenetic male pseudohermaphroditism and reduced prenatal growth. N Engl J Med 345:1135.
214. Rossignol S, Netchine I, Le Bouc Y, Gicquel C 2008 Epigenetics in Silver-Russell syndrome. Best Pract Res Clin Endocrinol Metab 22:403-414
215. Costa EMF, Correa RV, Mello KFAS, Arnhold IJ, Mendonca BB 2001 Male pseudohemaphroditism associated with low birthweight. Pediatric Research 49:57A
216. Morel Y, Rey R, Teinturier C, Nicolino M, Michel-Calemard L, Mowszowicz I, Jaubert F, Fellous M, Chaussain JL, Chatelain P, David M, Nihoul-Fekete C, Forest MG, Josso N 2002 Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 161:49-59.
217. Main KM, Jensen RB, Asklund C, Hoi-Hansen CE, Skakkebaek NE 2006 Low birth weight and male reproductive function. Horm Res 65 Suppl 3:116-122
218. Berkovitz, GD 1991 Clinical and pathologic spectrum of 46,XY gonadal dysgenesis: its relevance to the understanding of sex differentiation. Medicine 70
219. Fukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, Nordenskjold A, Camerino G, Kretz C, Buj-Bello A, Laporte J, Yamada G, Morohashi K, Ogata T 2006 CXorf6 is a causative gene for hypospadias. Nat Genet 38:1369-1371
220. Beleza-Meireles A, Tohonen V, Soderhall C, Schwentner C, Radmayr C, Kockum I, Nordenskjold A 2008 Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias. Eur J Endocrinol 158:729-739
221. Michel A, Mormont C, Legros JJ 2001 A psycho-endocrinological overview of transsexualism. Eur J Endocrinol 145:365-376
222. Migeon CJ, Wisniewski AB 1998 Sexual differentiation: from genes to gender. Horm Res 50:245-251
223. Meyer-Bahlburg HF 1994 Intersexuality and the diagnosis of gender identity disorder. Arch Sex Behav 23:21-40.
224. Meyer-Bahlburg HF 1984 Psychoendocrine research on sexual orientation. Current status and future options. Prog Brain Res 61:375-398
225. Costa EM, Mendonca BB, Inacio M, Arnhold IJ, Silva FA, Lodovici O 1997 Management of ambiguous genitalia in pseudohermaphrodites: new perspectives on vaginal dilation. Fertil Steril 67:229-232.
226. Khen-Dunlop N, Lortat-Jacob S, Thibaud E, Clement-Ziza M, Lyonnet S, Nihoul-Fekete C 2007 Rokitansky syndrome: clinical experience and results of sigmoid vaginoplasty in 23 young girls. J Urol 177:1107-1111
227. McGriff NJ, Csako G, Kabbani M, Diep L, Chrousos GP, Pucino F 2001 Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: a review of the literature. Pharmacotherapy 21:1425-1435
228. Denes FT, Cocuzza MA, Schneider-Monteiro ED, Silva FA, Costa EM, Mendonca BB, Arap S 2005 The laparoscopic management of intersex patients: the preferred approach. BJU Int 95:863-867
229. Sircili MH, de Mendonca BB, Denes FT, Madureira G, Bachega TA, e Silva FA 2006 Anatomical and functional outcomes of feminizing genitoplasty for ambiguous genitalia in patients with virilizing congenital adrenal hyperplasia. Clinics 61:209-214
230. Nihoul-Fékété, C 2006 Long-term surgical results and patient satisfaction with male pseudohermaphroditism or true hermaphroditism: a cohort of 63 patients. J Urol 175:1878-1884
231. Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH 2006 Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 27:468-484
232. Katz MD, Kligman I, Cai LQ, Zhu YS, Fratianni CM, Zervoudakis I, Rosenwaks Z, Imperato-McGinley J 1997 Paternity by intrauterine insemination with sperm from a man with 5alpha-reductase-2 deficiency. N Engl J Med 336:994-997.
233. Plante BJ, Fritz MA 2008 A case report of successful pregnancy in a patient with pure 46,XY gonadal dysgenesis. Fertil Steril